Global Neuromodulation Devices Market OverviewThe global neuromodulation devices market is poised to witness substantial ...

Boston Scientific rides on strong neuromodulation momentum as sales climb, new technologies gain traction and recent acquisitions expand its pain-treatment reach.

Analysts remain high on Boston Scientific after a visit to the company's Marlborough, Massachusetts headquarters.

Medtronic MDT is set to release second-quarter fiscal 2026 results on Nov. 18, before the market opens. The MedTech giant posted earnings per share (EPS) of $1.26 in the last reported quarter, which ...

University Orthopedics’ East Bay Surgery Center in East Providence, R.I., has become the first site in the state to implant a closed-loop spinal cord stimulator. Shiqiang “Chris” Tian, MD, an ...

Spinal cord injury (SCI) rostral to the lumbar locomotor center disrupts communication between the brain and the spinal ...

Onward’s Arc-Ex earned FDA 510(k) clearance for use at home, according to a Nov. 17 news release. The device is cleared for “use in conjunction with functional task practice in the clinic and ...

The FDA has cleared home use of a device that helps people with spinal cord injuries regain mobility and functioning.

Onward Medical announced today that it received FDA 510(k) clearance to expand the ARC-EX system's indication for home use.

The Global Spinal Implants And Surgery Devices Market Size projected to grow at a CAGR of 4.3% from 2026 to 2032, according ...

Mordor Intelligence has published a new report on neuromodulation market offering a comprehensive analysis of trends, growth drivers, and future projections.